Cost-Minimization Analyses of Adalimumab Compared with Selective Immunosuppressive Cytokines Blockers and Inhibitors of Tumor Necrosis Factor Alpha Indicated for the Treatment of Rheumatoid Arthritis, Psoriasis and Crohn’s Disease in the Private Market in Mexico
作者
CA Pichardo-Piña,J.L. Sanchez-Casillas,Juan Carlos Pozos-Espíndola
出处
期刊:Value in Health [Elsevier BV] 日期:2015-10-20卷期号:18 (7): A843-A843被引量:1